peapack gladston finl. - PGC
PGC
Close Chg Chg %
30.42 -0.32 -1.05%
Open Market
30.10
-0.32 (1.05%)
Volume: 18.83K
Last Updated:
Jul 11, 2025, 11:35 AM EDT
Company Overview: peapack gladston finl. - PGC
PGC Key Data
| Open $30.05 | Day Range 29.91 - 30.21 |
| 52 Week Range 22.41 - 37.88 | Market Cap $539.53M |
| Shares Outstanding 17.74M | Public Float 14.93M |
| Beta 0.85 | Rev. Per Employee N/A |
| P/E Ratio 16.92 | EPS $1.81 |
| Yield 65.75% | Dividend $0.05 |
| EX-DIVIDEND DATE May 8, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 80.05K |
PGC Performance
| 1 Week | 0.13% | ||
| 1 Month | 12.67% | ||
| 3 Months | 21.92% | ||
| 1 Year | 26.22% | ||
| 5 Years | 79.47% |
PGC Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
4
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | BUY | Average Target Price | 35.50 | |
| Number of Ratings | 4 | Current Quarters Estimate | 0.708 | |
| FY Report Date | 09 / 2025 | Current Year's Estimate | 2.55 | |
| Last Quarter’s Earnings | 0.605 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 1.85 | Next Fiscal Year Estimate | 3.875 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 4 | 4 | 4 | 4 |
| Mean Estimate | 0.71 | 0.79 | 2.55 | 3.88 |
| High Estimates | 0.77 | 0.91 | 2.74 | 4.21 |
| Low Estimate | 0.67 | 0.70 | 2.46 | 3.44 |
| Coefficient of Variance | 6.15 | 11.02 | 5.02 | 8.66 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 4 | 4 | 4 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 0 | 0 | 0 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Buy | Buy | Buy |
SEC Filings for Peapack Gladston Finl. - PGC
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Peapack Gladston Finl. - PGC
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Apr 2, 2025 | Beth Welsh Director | 15,497 | Open market or private purchase of non-derivative security Non-derivative transaction at $28.54 per share | 442,284.38 |
| Apr 2, 2025 | Duffield Meyercord Director | 140,372 | Open market or private purchase of non-derivative security Non-derivative transaction at $28.44 per share | 3,992,179.68 |
| Apr 2, 2025 | Edward A. Gramigna Director | 17,836 | Open market or private purchase of non-derivative security Non-derivative transaction at $28.43 per share | 507,077.48 |
| Apr 1, 2025 | Douglas L. Kennedy President & CEO | 35,409 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $28.58 per share | 1,011,989.22 |
| Mar 25, 2025 | Douglas L. Kennedy President & CEO | 11,689 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 25, 2025 | Maureen E. Hemhauser EVP & Chief Risk Officer | 5,272 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $29.55 per share | 155,787.60 |
| Mar 25, 2025 | Maureen E. Hemhauser EVP & Chief Risk Officer | 4,197 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 25, 2025 | Francesco S. Rossi SVP/Chief Accounting Officer | 5,204 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $29.55 per share | 153,778.20 |
| Mar 25, 2025 | Francesco S. Rossi SVP/Chief Accounting Officer | 3,240 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 25, 2025 | Maureen E. Hemhauser EVP & Chief Risk Officer | 4,549 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 25, 2025 | Lisa P. Chalkan EVP, Chief Credit Officer | 4,899 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 25, 2025 | Lisa P. Chalkan EVP, Chief Credit Officer | 4,233 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 25, 2025 | Douglas L. Kennedy President & CEO | 43,742 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 25, 2025 | Douglas L. Kennedy President & CEO | 40,409 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $28.79 per share | 1,163,375.11 |
| Mar 25, 2025 | Frank A. Cavallaro SEVP & Chief Financial Officer | 7,499 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 25, 2025 | Frank A. Cavallaro SEVP & Chief Financial Officer | 6,614 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 25, 2025 | Robert A. Plante EVP, Chief Operating Officer | 12,847 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 25, 2025 | Stuart M Vorcheimer EVP, Comm & Ind Lndg | 4,688 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 25, 2025 | Lisa P. Chalkan EVP, Chief Credit Officer | 26,102 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $29.55 per share | 771,314.10 |
| Mar 25, 2025 | Robert A. Plante EVP, Chief Operating Officer | 3,142 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Peapack Gladston Finl. in the News
How First Republic rescue, Silicon Valley Bank could cost Main Street America
In wake of recent issues with First Republic and Silicon Valley Bank, community bank leaders tell FOX Business that sharing the financial burden with larger institutions is unfair.